Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Kyntra Bio Inc (KYNB) had Cost of Goods Sold of $0.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$-1.47M |
|
$11.97M |
|
|
Cost of Goods Sold |
$0.00M |
$-1.48M |
|
$16.10M |
|
$-17.57M |
|
$29.55M |
|
$11.97M |
|
$-18.97M |
|
$11.97M |
|
$11.97M |
|
$11.97M |
|
$-18.96M |
|
$-17.57M |
|
$-17.67M |
|
4.05M |
|
4.05M |
|
$2.96 |
|
$2.96 |
|
| Balance Sheet Financials | |
$96.83M |
|
-- |
|
$4.25M |
|
$101.08M |
|
$36.04M |
|
-- |
|
$94.66M |
|
$130.70M |
|
$-29.62M |
|
$-29.62M |
|
$-29.62M |
|
4.05M |
|
| Cash Flow Statement Financials | |
$-17.88M |
|
$20.69M |
|
$-0.01M |
|
$47.87M |
|
$50.64M |
|
$2.77M |
|
$2.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.14% |
|
1192.27% |
|
1192.27% |
|
-- |
|
-812.28% |
|
-812.35% |
|
$-17.88M |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
0.00 |
|
-4.25 |
|
-21.19 |
|
-40.42% |
|
-40.42% |
|
11.85% |
|
-40.42% |
|
$-7.32 |
|
$-4.42 |
|
$-4.42 |
|